Mackenzie Financial Corp Buys New Position in Mesa Laboratories, Inc. (NASDAQ:MLAB)

Mackenzie Financial Corp purchased a new position in Mesa Laboratories, Inc. (NASDAQ:MLAB) during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 6,867 shares of the medical instruments supplier’s stock, valued at approximately $596,000. Mackenzie Financial Corp owned approximately 0.13% of Mesa Laboratories at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently bought and sold shares of the business. Louisiana State Employees Retirement System boosted its stake in shares of Mesa Laboratories by 4.0% during the 2nd quarter. Louisiana State Employees Retirement System now owns 2,600 shares of the medical instruments supplier’s stock worth $226,000 after acquiring an additional 100 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its position in shares of Mesa Laboratories by 6.5% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 2,873 shares of the medical instruments supplier’s stock valued at $316,000 after purchasing an additional 175 shares during the period. EntryPoint Capital LLC increased its stake in Mesa Laboratories by 35.2% in the 1st quarter. EntryPoint Capital LLC now owns 741 shares of the medical instruments supplier’s stock worth $81,000 after purchasing an additional 193 shares in the last quarter. Canada Pension Plan Investment Board purchased a new position in Mesa Laboratories in the 2nd quarter worth about $26,000. Finally, BNP Paribas Financial Markets raised its holdings in Mesa Laboratories by 4.5% during the 1st quarter. BNP Paribas Financial Markets now owns 7,565 shares of the medical instruments supplier’s stock worth $830,000 after buying an additional 327 shares during the period. 90.60% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Mesa Laboratories

In other Mesa Laboratories news, SVP Brian David Archbold sold 1,499 shares of the business’s stock in a transaction that occurred on Friday, September 13th. The shares were sold at an average price of $125.00, for a total value of $187,375.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 5.20% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have commented on MLAB. Wells Fargo & Company assumed coverage on shares of Mesa Laboratories in a report on Tuesday, August 27th. They issued an “underweight” rating and a $120.00 target price for the company. Evercore ISI lifted their price objective on shares of Mesa Laboratories from $120.00 to $160.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 1st.

Mesa Laboratories Price Performance

Shares of MLAB opened at $133.58 on Friday. The company has a debt-to-equity ratio of 1.38, a current ratio of 1.94 and a quick ratio of 1.37. The company has a market capitalization of $722.53 million, a price-to-earnings ratio of -2.83 and a beta of 0.85. The business’s 50-day moving average is $124.84 and its 200-day moving average is $111.33. Mesa Laboratories, Inc. has a fifty-two week low of $82.86 and a fifty-two week high of $141.17.

Mesa Laboratories (NASDAQ:MLAB) last released its quarterly earnings data on Monday, August 5th. The medical instruments supplier reported $2.29 earnings per share for the quarter, beating the consensus estimate of $1.74 by $0.55. The firm had revenue of $58.17 million for the quarter, compared to analyst estimates of $55.90 million. Mesa Laboratories had a negative net margin of 111.89% and a positive return on equity of 18.95%. Equities research analysts expect that Mesa Laboratories, Inc. will post 7.91 EPS for the current fiscal year.

Mesa Laboratories Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, December 16th. Investors of record on Friday, November 29th will be issued a dividend of $0.16 per share. The ex-dividend date of this dividend is Friday, November 29th. This represents a $0.64 annualized dividend and a dividend yield of 0.48%. Mesa Laboratories’s dividend payout ratio is -1.36%.

Mesa Laboratories Company Profile

Mesa Laboratories, Inc develops, manufactures, and sells life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. It operates in four segments: Clinical Genomics, Sterilization and Disinfection Control, Biopharmaceutical Development, and Calibration Solutions.